VAPOTHERM, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.85 USD | -1.16% |
|
-35.61% | -15.00% |
Presenter SpeechJohn Landry (Executives)Good morning, everyone. Good morning. My name is John ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.
Calendar
05/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -15.00% | 5.35M | |
| +12.15% | 228B | |
| +14.90% | 196B | |
| +18.22% | 141B | |
| +29.15% | 110B | |
| +0.53% | 65.88B | |
| +16.92% | 54.3B | |
| +6.33% | 52.39B | |
| +10.93% | 45.22B | |
| +5.87% | 37.12B |
- Stock Market
- Equities
- VAPO Stock
- News Vapotherm, Inc.
- Transcript : Vapotherm, Inc. - Analyst/Investor Day
